CY 208-243 structure
|
Common Name | CY 208-243 | ||
---|---|---|---|---|
CAS Number | 100999-26-6 | Molecular Weight | 274.36000 | |
Density | 1.225 g/cm3 | Boiling Point | 466.5ºC at 760 mmHg | |
Molecular Formula | C19H18N2 | Melting Point | 227-228ºC | |
MSDS | N/A | Flash Point | 236ºC |
Use of CY 208-243CY 208-243 is a selective dopamine D1 receptor agonist which exhibits antiparkinsonian activity[1]. |
Name | CY 208-243,(-)-(6aR,12bR)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-a]phenanthridin |
---|---|
Synonym | More Synonyms |
Description | CY 208-243 is a selective dopamine D1 receptor agonist which exhibits antiparkinsonian activity[1]. |
---|---|
Related Catalog | |
Target |
dopamine D1 receptor[1] |
In Vivo | Pretreatment with CY 208-243 (2.5 mg/kg; s.c.) prevents the increase of DA release and metabolism induced by the D-1 antagonist, SCH 23390 (0.05 mg/kg; s.c.)[1]. Animal Model: Male Sprague-Dawley rats (180-200 g)[1] Dosage: 2.5 mg/kg Administration: Subcutaneous Result: Prevented the increase of DA release and metabolism induced by the D-1 antagonist. |
References |
Density | 1.225 g/cm3 |
---|---|
Boiling Point | 466.5ºC at 760 mmHg |
Melting Point | 227-228ºC |
Molecular Formula | C19H18N2 |
Molecular Weight | 274.36000 |
Flash Point | 236ºC |
Exact Mass | 274.14700 |
PSA | 19.03000 |
LogP | 3.60780 |
Vapour Pressure | 7.02E-09mmHg at 25°C |
Index of Refraction | 1.697 |
Precursor 1 | |
---|---|
DownStream 0 |
SynaptoRedTM C2 |